Key Highlights

  • NewGenIvf Group Limited (NASDAQ:NIVF) fell 13.01% to about USD 1.27 in early trading on Monday, October 26, 2026, after a 1-for-4 reverse split and a scheduled 1-for-8 step, a combined ratio of 1-for-32.
  • DarkIris Inc. (NASDAQ:DKI) fell 12.50% to about USD 1.89 four days after a 1-for-50 consolidation, following a best-efforts offering of about USD 6 million with warrants exercisable at USD 2.04.
  • China SXT Pharmaceuticals (NASDAQ:SXTC) fell 13.90% to USD 3.53 on the first session after a 1-for-100 consolidation, and iPower Inc. (NASDAQ:IPW) rose about 11.9% to near USD 2.73 on its 1-for-12 split date.
  • Each split cut the share count sharply to a float of roughly one million shares or fewer, so moves of 11.9% to 13.9% reflect thin liquidity and, for three names, new share supply.

NewGenIvf (NASDAQ:NIVF): two consolidations in two weeks

NewGenIvf Group Limited (NASDAQ:NIVF), which offers fertility and assisted reproduction services in Asia, traded about 13.01% lower at roughly USD 1.27 in early trading on Monday, October 26, 2026, with prices intraday. The company has not issued a release explaining the move. A 1-for-4 reverse split of Class A ordinary shares took effect at 12:01 a.m. ET on Monday, October 12, 2026, and a 1-for-8 ratio was scheduled for Friday, October 23, 2026, according to exchange notices.

On the company's figures, the first step cut Class A shares from about 35,688,329 to about 8,922,083 as of Tuesday, October 6, 2026, although convertible note exercises could raise the count. The second step would, by simple arithmetic, leave roughly 1.1 million shares before new issuance. Convertible notes let a lender exchange debt for new shares, so each conversion enlarges a very small base. With a float that thin, a few orders can move the price by double digits. Companies in this position often use splits to restore compliance with the USD 1.00 minimum bid price, and the principal risk is that conversions pressure the price even after the adjustment.

DarkIris (NASDAQ:DKI): a USD 6 million offering before a 1-for-50 split

DarkIris Inc. (NASDAQ:DKI), which develops and operates mobile games and is moving into AI-generated video, traded about 12.50% lower at roughly USD 1.89 in early trading on Monday, October 26, 2026. The company has not issued a release explaining the move. A 1-for-50 consolidation, effective Thursday, October 22, 2026, cut Class A shares from 46,731,225 to about 934,625. It followed a 1-for-16 step effective Monday, May 11, 2026, so the two combine to 1-for-800. A pre-consolidation close near USD 0.04 scales to about USD 2.00.

Financing preceded the split. On Thursday, October 8, 2026 the company priced a best-efforts offering of 4,166,666 units at USD 1.44, each with a Class A share and a warrant exercisable at USD 2.04 for six months, for gross proceeds near USD 6 million. The latest half year showed a net loss of USD 1.90 million and cash of USD 0.47 million before the offering. Warrant exercises could add shares to a base below one million. The company's AI film platform remained in pre-launch compliance review on Wednesday, September 30, 2026, so the operating case is still unproven.

China SXT Pharmaceuticals (NASDAQ:SXTC): a USD 12 million offering and a 1-for-100 consolidation

China SXT Pharmaceuticals (NASDAQ:SXTC), a Chinese maker of traditional Chinese medicine products, traded at USD 3.53 in early trading on Monday, October 26, 2026, down 13.90% on a split-adjusted basis, which implies a prior close near USD 4.10, calculated from the move. Its 1-for-100 consolidation of Class A ordinary shares took effect at the open, cutting the count from 68,677,500 to about 686,775, with fractional shares rounded up. The company has not stated its purpose in the release of Thursday, October 22, 2026. Delayed pre-split prices of USD 0.05 to USD 0.073 on Thursday, October 22, 2026 mean part of the move is an artefact of the new share count.

The company announced a USD 12 million registered direct offering on Thursday, October 8, 2026, with an option to buy up to a further USD 12 million within 30 days of closing. Warrants sold alongside add shares on exercise, and the company has not stated whether the split addresses a minimum bid requirement. After a consolidation the float is very small, so prices can swing widely and often drift back after the adjustment. Investors should watch trading on Tuesday, October 27, 2026 and any filing on warrant exercises, since each new share reduces the percentage owned by existing holders.

iPower (NASDAQ:IPW): a split day with an AI services letter

iPower Inc. (NASDAQ:IPW), known for online hydroponics and home and garden supplies, rose about 11.9% to near USD 2.73 in early trading on Monday, October 26, 2026, the date of its announced 1-for-12 reverse split. The price corresponds to about USD 0.23 on the old basis. The company has not issued a release explaining the move beyond the split, and a quoted change can partly reflect how market data providers adjust history.

The only recent company catalyst is a five-year services letter of intent announced on Thursday, October 15, 2026, targeting USD 21.90 million of potential annualised services. The letter is non-binding, so revenue is not assured, and USD 21.90 million would be large relative to a micro cap. Unlike the other three names, no new offering has been disclosed, but tariffs and consumer demand have pressured margins for importers of home and garden products, and reverse splits are often followed by weaker prices when low liquidity returns. A definitive agreement on the services contract, any financing that follows the split and the next quarterly report, for which the company has yet to give a date, are the items to follow.

Where Things Stand

The answer is that reverse splits reset the quoted price but not value, so these shares now trade as very small floats where financing decides direction. NewGenIvf (NASDAQ:NIVF) combined 1-for-4 and 1-for-8 steps into 1-for-32 with convertible notes outstanding, DarkIris (NASDAQ:DKI) paired 1-for-50 with warrants at USD 2.04 just above its USD 1.89 price, and China SXT Pharmaceuticals (NASDAQ:SXTC) paired 1-for-100 with a USD 12 million offering. iPower (NASDAQ:IPW) rose 11.9% on a non-binding letter and a mechanical adjustment. The next catalysts are trading on Tuesday, October 27, 2026 and the Federal Reserve decision on Wednesday, October 28, 2026, followed by filings on conversions and warrant exercises. Intraday prices can reverse, small caps are volatile, and this is not investment advice.